Gynesonics commences study for the VizAblate system
Gynesonics has begun a multicentre clinical trial to assess the effectiveness of the VizAblate system for the treatment of uterine […]
Say something
Gynesonics has begun a multicentre clinical trial to assess the effectiveness of the VizAblate system for the treatment of uterine […]
Global pharma giant GlaxoSmithKline is eyeing acquisitions worth $ 2 billion in India, the world’s fastest-growing drug market, media reports […]
With a hospital information system already in place, Manipal Hospitals is planning an expansion spree by connecting all its hospitals through an HIS. Dr Nagendra Swamy oversees, among other responsibilities, the functioning and operations of the Bangalore Cluster of Manipal Hospitals.
Pharmaceutical Research and Manufacturers of America (PhRMA) President and CEO John J. Castellani issued the following statement today on receiving recognition from The Rotary Foundation of Rotary International.
Recent analysis shows that the high priced research and development companies which show $1.3 billion cost are not real.
President and Managing Director, MSD Pharmaceuticals Limited K G Ananthakrishnan and leading paedetrician, Dr Manjira Mitra, announced the national launch of the unique health product in India.
Aurbindo pharma looses 0.91 percent stakes possessed by HSBC Global Investment Funds (Mauritius) Ltd in the open market sales.
The industry department is about to finalise the terms under which the government can order the manufacture of drugs without seeking the permission of the patent holder by the end of this month.
The research-based pharma companies are mounting pressure for stronger regulatory data protection laws.